ÂÜÀòÂÒÂ×

Dr. Donald founded PHIGENIX, Inc. Pharmaceutical and Biomedical Research Company in 2007, and is the inventor of the intellectual property around which the company is based. Prior to joining PHIGENIX, Dr. Donald was a professor at the Medical University of South Carolina and has over 25 years of experience as cancer biologist. He has published a number of ground-breaking, peer-reviewed articles, has over 36 abstracts and has received national and international recognition for his work. Dr. Donald received his BS degree in biology from Florida A&M University, his M.S. and Ph.D. in Molecular Biology from Clark Atlanta University and completed two postdoctoral fellowships at Emory University including one in molecular urologic therapeutics.